Professor in abdominal imaging in Paris, France, specialized in liver imaging, and digestive oncoloy imaging.

Daniel Goh is currently a Senior Staff Nurse at the Department of Diagnostic Radiology at Tan Tock Seng Hospital, Singapore.

He graduated from the University of Adelaide quite a while ago with a Bachelor of Nursing degree. He also held an Advanced Diploma from the Nanyang Polytechnic specialising in Perianaesthesia.

His interest is in the field of Anaesthesia. He is currently supporting his department in most of their cases that require anaesthesia support as an AU nurse.

Prior to joining Inari, Dr. Niekamp was a Vascular Interventional Radiologist with Radiology Associates of South Florida and joined the group in July of 2020. He also practiced at Baptist Hospital of Miami, South Miami Hospital and Doctors Hospital. Dr. Niekamp received his undergraduate degree and medical degree from The Ohio State University and completed his post-graduate training at the University of Texas at Houston/M.D. Anderson Cancer Center. He completed his fellowship in Vascular Interventional Radiology at the Miami Cardiac and Vascular Institute. Following fellowship, he joined the faculty at Miami Cardiac and Vascular Institute and was a practicing attending until March 2024. Dr. Niekamp has been an investigator in multiple clinical research trials and is the author of numerous papers and abstracts. During his time in practice, Dr. Niekamp had a particular focus on treating patients suffering from venous thromboembolism.

Dr Joel Zhou is an Associate Consultant at the Department of Diagnostic Radiology in Tan Tock Seng Hospital, Singapore. He graduated from the University of New South Wales, Sydney, and completed his radiology training in Singapore with the National Healthcare Group Residency Programme. He obtained a Master of Medicine (Radiology), National University of Singapore (NUS) and became a fellow of the Royal College of Radiologists. Dr Zhou’s subspecialty interests are in interventional radiology and abdominal imaging.

Dr Tan Bien Soo is Senior Consultant at the Department of Vascular and Interventional Radiology, Singapore General Hospital. Dr Tan is Clinical Professor at the Duke-NUS Medical School, and also an Honorary Professor at the Department of Medical Science, Development and Management University of Medicine 1, Yangon, Myanmar. He was the inaugural Academic Chair of the Radiological Sciences Academic Clinical Programme at the SingHealth Duke-NUS Academic Centre from 2014 to 2020, the Chair of the Division of Radiological Sciences at Singapore General Hospital from 2017 to 2020, and the Head of the Department of Diagnostic Radiology, Singapore General Hospital from 2002 to 2010.

I joined SKH since July 2017. I am working in Department of Radiology and I am specialised in Interventional Radiology. I have been working in this specialty for more than 10 years and I enjoy working with my team mates as a team. I have learnt alot in IR with new skills and knowledge. I am given an opportunity to learn to be an assessor and a preceptor so I can teach new juniors who join IR and to assess their competency.

Mr. Padre is a Radiographer specialized in interventional imaging at Radiography Department of Singapore General Hospital.
Mr. Padre, is a graduate of Saint Louis University in Baguio City, Philippines, Batch 1987 with a Diploma in Radiologic Technology. In September 2015, completed the Bachelor of Science (Hons) Radiographic Studies, London South Bank University.
Mr. Padre have been practicing Diagnostic Radiography for 37 years. Prior to joining SGH in the year 2000, he acquired clinical experience in Diagnostic Radiology and Computerized Imaging Institute at Makati Medical Center, Philippines.

Since 2008, he has been continuously operating the Hybrid Angiography-CT system and embracing the challenge to develop and improve the Intra-arterial CT Angiography protocols and its imaging clinical application in Interventional Radiology.
His knowledge in Intra-arterial CT Angiography techniques and related sciences has been improved through recognition in different conferences in the local, regional and international scene.

Mr. Padre is currently working as a Clinical Principal Radiographer in interventional imaging of Singapore General Hospital.

Dr Law Yan Mee is a Senior Consultant at the Department of Diagnostic Radiology in Singapore General Hospital (SGH) and Clinical Assistant Professor at the Duke NUS Medical School. Dr Law has earned a strong professional reputation in Singapore and international medical communities in the field of abdominal imaging, particularly in genitourinary radiology. She received her postgraduate degree from the Royal College of Radiologists in 2005 and underwent advanced radiology training in the Singapore General Hospital (SGH). In 2008, she was one of the first local radiologists to be fellowship trained in the subspecialty of genitourinary imaging in University of North Carolina, Chapel Hill. In 2013, she was selected to collaborate at the National Institute of Health (NIH), USA in advanced prostate cancer MRI imaging, where she co-authored over 14 peer-reviewed scientific publications and 2 book chapters with leading world experts in the field. These collaborations to advance this critical field of cancer diagnosis with cutting edge research are on-going today. In the present day, Dr Law is a key member of a global panel of radiologists participating in ground-breaking projects to validate the use of artificial intelligence (AI) deep learning for MRI prostate imaging. This initiative holds the potential to significantly enhance the quality of early prostate cancer diagnosis based on MRI.

Dr Law contributed much to magnetic resonance imaging (MRI) of prostate in Singapore. Her expertise in genitourinary radiology is highly sought after by her clinical colleagues in SGH. Urologists across the country and the region frequently seek her expert opinions on complex MRI prostate cases, highlighting her significant impact on patient care and safety, particularly in our aging communities. Her primary area of interest lies in prostate cancer imaging, with a particular focus on early prostate cancer and prostate cancer focal therapy, a rapidly evolving field.

Karthikeyan Damodharan
MBBS, MRCP (UK), FRCR (UK), FCIRSE, EBIR, FAMS

Dr. Karthik is a distinguished expert in Vascular & Interventional Radiology with over 15 years of extensive experience across the US, UK, and Singapore. Currently serving as the Director of Vascular & Interventional Radiology at MIOT Hospitals International in Chennai, India, Dr. Karthik has a proven track record of excellence and innovation in his field.

Dr. Karthik’s medical journey began at the Madras Medical College in India, where he earned his medical degree. Driven by a passion for advancing his expertise, he pursued postgraduate training in the UK. He attained the esteemed membership of the Royal College of Physicians (MRCP) and the fellowship of the Royal College of Radiologists (FRCR) in 2007. He completed his Certificate of Completion of Specialist Training (CCST) in 2010.

Dr. Karthik embarked on a Fellowship in Vascular & Interventional Radiology at the Cleveland Clinic, USA, one of the most respected medical centers worldwide. Following his fellowship, he served as a Consultant Interventional Radiologist in the NHS, UK, for two years.
Dr. Karthik’s career then led him to Singapore General Hospital, where he worked as a Senior Consultant for six years. His leadership and vision were instrumental in setting up the interventional radiology services at Sengkang General Hospital, where he served as the Clinical Lead for two years.

In 2020, Dr. Karthik returned to India, bringing his wealth of international experience to MIOT Hospitals International, Chennai. His special interests include aortic, peripheral vascular, and hepatobiliary interventions.

Dr. Karthik is also a prolific contributor to medical research, with over 30 research articles published in leading peer-reviewed journals. His expertise and insights are highly sought after, and he has been invited to speak at numerous international conferences, sharing his knowledge and advancements in the field of interventional radiology.

Qualifications Obtained
2022: Specialist Diploma in Radiology Nursing conducted by Nanyang Polytechnic.
2018: Certificate of Achievement in Advanced Thoracic Nursing Course conducted by Tan Tock Seng Hospital.
2018: Bachelor of Nursing conducted by the School of Nursing and Midwifery, La Trobe University, Melbourne, Australia.

Work / Practice History
2010-Present: Joined Diagnostic Interventional Radiology in Tan Tock Seng Hospital
Position held: Assistant Nurse Clinician

Sin is a dedicated Senior Principal Radiation Therapist at the National Cancer Centre Singapore (NCCS). She graduated with Masters in Radiation Therapy from MONASH University Australia in 2004 and has been practicing for 20 years. Since 2012, she has been specializing in Head and Neck (HN) radiation therapy and has emerged as the 1st Advanced Practice Radiation Therapist (APRT) in Singapore.
Sin is known for her expertise in Image-Guided Radiotherapy (IGRT) and Clinical Toxicity Assessment in Head and Neck cancer. She is the 1st RTT who approves images alongside with the HN Radiation Oncologists and performs clinical assessment for NPC and HN Proton patients. Furthermore, she develops the Imaging Protocols and committed to educate RTTs and students. Her current roles include leading and developing key departmental HN initiatives in both Proton and Photon therapy. Sin believes in fostering strong teamwork and inter-professional collaboration to achieve high standards of care and better outcomes for HN radiotherapy patients.
Her international experiences include invited speaker, oral presentations and posters in USA, Europe, Australia, Singapore, Taiwan and Malaysia, specializing in HN radiotherapy, imaging and advanced practice.

Dr Tan is a senior consultant medical oncologist at the National University Cancer Institute, Singapore and an Associate Professor in the Department of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore and Principal Investigator at the Cancer Science Institute, National University of Singapore. His primary clinical and research interests are in gynaecological cancers, precision oncology, and early phase trials. He has authored over 100 peer-reviewed scientific papers and received several awards for his research (see link to publications: https://discovery.nus.edu.sg/4508-shao-peng-david-tan/publications). Dr Tan is currently the Head of the Innovation Transfer Office at National University Health Systems (NUHS) and Director of the Research Transformation Office at NUHS. He was the founding President of the Gynecologic Cancer Group Singapore (GCGS), and inaugural President of the Asia-Pacific Gynaecologic Oncology Trials (APGOT) Group. He currently chairs the APGOT Protocol Review Committee. He currently also chairs the Cervical Cancer Research Network (CCRN) of the of the Gynecologic Cancer InterGroup (GCIG) and is a member of the executive board of directors of the GCIG.

Vice Chair of Diagnostic Radiology & Cardiovascular Imaging for the Dept of Radiology at Texas Children’s Hospital, affiliated to Baylor College of Medicine in Houston, Texas. Division Chief for Body Radiology since 2018. Fellowships in Pediatric, Cardiothoracic, Body MR and Neuroimaging. Research grants involve utility of MR imaging biomarkers in leukemia induced hepatotoxicity, MR Elastography in Non-alcoholic steatohepatitis, MRI Biomarkers in primary sclerosing cholangitis. Expertise in pediatric liver imaging, pediatric cardiovascular CT & MRI, inflammatory bowel disease and whole body MRI screening in cancer predisposition syndromes.

Dr Toh Han Chong is Deputy CEO (Strategic Partnerships), National Cancer Centre Singapore and tenured Professor at the Duke NUS Medical School. Dr Toh obtained the International Baccalaureate diploma at the Lester B. Pearson College, Canada on a United World College Scholarship. He obtained his BSc (Intercalated) from the University of London in ‘Infection and Immunity’ and his medical degree from the University of Cambridge, UK. His oncology and research training were at the Singapore General Hospital, Massachusetts General Hospital, Harvard Medical School and at the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Texas, USA. Dr Toh is alumni of the Harvard Business School General Management Program. He is Principal Lead, Cellular Immunotherapy at the Singhealth Duke NUS Cell Therapy Centre. He is co-founder of a clinical stage cell therapy startup NeoTILa, which recently won 1st prize in the global health category (and overall 3rd) in the Wolfson Entrepreneurship Competition, Cambridge University, UK.

Dr Toh is recipient of National Senior Clinician Scientist Award in 2017 and National Medical Excellence Award (NMEA) in 2018 for his pioneering work in cell and immunotherapy for cancer. He leads the NMRC Large Collaborative Grant VICTORY (Virus-Induced Cancers Translational Oncology and immunologY) grant and is recipient of the NMRC STaR Award 2022 focusing on the translational understanding and therapeutic development for hepatocellular carcinoma.

Dr Toh is European Society for Medical Oncology (ESMO) faculty for Cancer Immunology and on the ESMO Scientific Committee 2024 and also co-lead of the ESMO Asia Immunotherapy Education section which he will chair. He is also on the Scientific Organising Committee for APPLE – Asia-Pacific Primary Liver Cancer Expert Meeting 2024. He is co-founder of the Asia-Pacific Gastrointestinal Cancer Summit (APGCS).

Dr Toh has published over 150 peer review journal papers.

Dr. Tannai is an assistant professor of diagnostic radiology at Tohoku University in Sendai, Japan. He graduated from Tohoku University in 2013. He trained in diagnostic radiology at hospitals in Yokohama and Tokyo, and obtained board certification as a diagnostic radiologist and interventional radiologist. During his training, he was involved in adrenal vein sampling (AVS) for primary aldosteronism, especially segmental AVS involving tributaries of the adrenal gland, at Yokohama Rosai Hospital, which has the highest annual number of AVS procedures in Japan. He conducted research and published papers on this topic and received his PhD from Yokohama City University. Since 2022, he has returned to his alma mater, where he is currently engaged in body imaging diagnostics and interventional radiology, including sAVS and radiofrequency ablation.

M.D, Ph.D., Professor, chief physician, doctoral supervisor, postdoctoral fellow at Johns Hopkins. Chairman of the Radiology Department at Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology.
Member of the Abdominal Professional Committee of the Radiology Branch of the Chinese Medical Association, Standing Committee Member of the Tumor Imaging Professional Committee of the Chinese Anti Cancer Association, Member of the Chinese Pancreatic Disease Society, Member of the Digestive Imaging Professional Committee of the Radiology Branch of the Chinese Medical Association, Member of the Contrast Agent Professional Committee of the Radiology Branch of the Chinese Medical Association, Executive Committee Member of the MDT Professional Committee of the International Hepatobiliary Pancreatic Society, Member of the Imaging Group of the Gastric Cancer Professional Committee of the Chinese Anti Cancer Association, Standing Committee Member of the Radiology Branch of the Hubei Medical Association, and Chairman of the Radiology Professional Committee of the Hubei Clinical Oncology Society.
More than 50 international conference prestations and posters were presented at RSNA, ISMRI, and ASSR. and over 150 peer-reviewd articles were published, including Radiology, Nature Machine Intelligence, Endoscopy, J Nanobiotechnology, Chemical Engineering Journal, Clin Transl Med, Gastrointestinal Endosc, IEEE Journal of Biomedical and Health Informatics, ER, MRM, AJR, JMRI, etc. Hosted 4 national natural science projects, 6 provincial and ministerial level projects. Received the 5th Chinese Government Publishing Award, Hubei Provincial Science and Technology Progress Award, and Ministry of Education Teaching Award.

Chief Physician
Research area: Artificial Intelligence in Oncology Imaging
Dr. Tong Tong received her PhD in imaging and nuclear medicine from Fudan University in 2008. Dr. Tong Tong is currently a chief physician of Fudan University Shanghai Cancer Center, and a doctoral supervisor at Fudan University. She is currently a member of the Magnetic Resonance Group Committee of the Chinese Society of Radiology, and a member of the Standing Committee of Oncology Imaging Committee of the China Anti-Cancer Association. Her current research is in the accurate clinical staging of rectal cancer, and the prediction and evaluation of neoadjuvant therapy efficacy of rectal cancer using functional magnetic resonance. She undertook a number of research projects of the National Natural Science Foundation of China as the first person in charge. In recent years, she has published more than 40 papers as the first author or corresponding author, including more than 30 SCI papers.

Daniel is currently the senior principal radiographer at the national cancer centre singapore, and is taking care of the ct and safety portfolio.

His clinical interests includes body imaging of oncology patients, and sustainability of ct services.

He has authored and co-authored numerous publications and presented at regional and international conferences regularly.

Dr Kum received his medical degree from the National University of Singapore in 2000 and subsequently embarked on his surgical training with the Royal College of Surgeons, obtaining his Master of Medicine and Fellowship in 2007. In 2009, he completed his Postgraduate Fellowship in Vascular and Endovascular Surgery at the Prince of Wales Hospital, Sydney as well as at the Department of Angiology, Heart Centre Leipzig. In 2012, he completed a second Fellowship on Advanced Techniques in Diabetic Limb Salvage and Wound Care Techniques in Milan. Dr Kum is a Certified Wound Specialist Physician by the American Board of Wound Management.

Since 2015, Dr Kum has been the Director of Vascular Surgery at Department of Surgery, Changi General Hospital Singapore and he was subsequently appointed as a Visiting Consultant in 2019. He currently maintains his practice at Mount Elizabeth Novena Hospital, Singapore.

Dr Kum is part of the organizing committee of LINC and VERVE meetings. He is the past President of the Society for Vascular and Endovascular Surgeons of Singapore (SVESS). He is a winner of multiple service quality awards from Singhealth and was awarded the prestigious Vascular Achievement Award in 2019 by the VIVA Foundation. Dr Kum maintains a close professional relationship with industry and sits on the Global Advisory Board of Abbott Vascular and Boston Scientific.

Dr Kum has a keen interest in clinical research revolving around Diabetic Limb Salvage. He is one of the pioneers in Percutaneous Deep Arterialization for no-option Critical Limb Ischemia for which he has authored or co-authored numerous papers. He is the PI or co-PI for several industry or physician-led studies. He is also a keen innovator and as the Chief Medical Officer of M & L Healthcare, is currently working on several disruptive technologies.

My research mainly is breast imaging in clinical work and research, with focus on breast MRI. I have been a founder and a group leader of breast imaging section in diagnostic imaging and nuclear medicine, Kyoto University since 2011. The main research theme of our group and myself includes ultrafast dynamic contrast enhanced MRI, diffusion-weighed image (DWI) of the breast. Most of my recent publications, both original and review papers focus on these topics. My team members have been awarded at ISMRM annual meeting and other meeting for their excellent scientific presentations. I have been invited to give lectures on breast MRI (10 international meetings, and more than 20 domestic meetings).

My research is not limited to MRI. I have been involved in dedicated breast PET (dbPET) as a new tool to evaluate breast lesions from the metabolic point of view. Our site is one of few academic sites which uses dbPET. We recently published a paper proposing new lexicon for dbPET, aiming to standardize imaging reports and analyze the data in a systematic way. With my background of breast MRI, I aim at using PET as a part of multiparametric imaging for more accurate local staging and response prediction. Another collaboration project is Development of Photoacoustic imaging (PAI) system.

Dr Lim is a Consultant in the Department of Diagnostic Radiology in Changi General Hospital, practising Interventional Radiology. He is also a Visiting Consultant with the Department of Vascular and Interventional Radiology at Singapore General Hospital.

He spent a year in Seoul National University Hospital as a Visiting Fellow in Interventional Radiology. His main clinical interests are in interventional oncology, especially hepatocellular carcinoma.

Dr. Andrew Makmur is the Group Chief Technology Officer (Designate) at the National University Health System (NUHS). A consultant radiologist at the National University Hospital of Singapore, He is at the forefront of integrating innovative technology in healthcare. He played a pivotal role as a co-inventor of the NUH/NUS School of Computing Spine AI model, which garnered notable publications and led to a partnership with Siemens for further development and potential global distribution.

Dr. Makmur has contributed significantly to the development of various imaging AI models, including those for detecting metastatic spine instability and grading, and has collaborated with the Health Promotion Board (HPB) on a mobile app for scoliosis X-ray screening. He oversees the NUH custom radiology AI deployment sandbox, aimed at integrating imaging AI models into clinical practice. Under his leadership, the Duplicate Radiology Scans Detection dashboard was developed on the NUHS Endeavour AI platform, enhancing scanner resource utilization and patient experience by detecting duplicate scans and MRI safety issues.

As the lead of the Generative AI Project Management Office, Dr. Makmur is key in developing NUHS-grown large language models, such as RUSSELL-GPT, supporting applications across medicine, surgery, radiology, and administrative domains.

Dr. Sundeep Punamiya is currently working as a Senior Consultant Radiologist at Tan Tock Seng Hospital, Singapore. His experience in Interventional Radiology has spanned over three decades in India and Singapore and has held positions as Chief of Interventional Radiology in Bombay Hospital from 1999-2007 and in Tan Tock Seng Hospital from 2011-2023. He has a special interest in hepatobiliary and gastrointestinal interventions specifically involving portal hypertension, Budd-Chiari syndrome, biliary disorders and GI stenting, and is a pioneer of the TIPS procedure. He has delivered over 250 invited lectures, workshops and live case demonstrations worldwide and has authored over 100 scientific articles, abstracts and chapters.
He has been actively involved in training, having headed fellowship training programs for Interventional Radiology in Mumbai and Singapore for over two decades, and to date is actively participating in the teaching and academic activities of Radiology and other clinical faculties.

Associate Consultant at the Department of Vascular and Interventional Radiology, Singhealth.

Dr Rahul Lohan graduated from the All India Institute of Medical Sciences (AIIMS), New Delhi in Jan 2007. He obtained his postgraduate qualification in radiology from the National University of Singapore and the Royal College of Radiologists, UK in 2012. In 2018-19, he completed 1 year fellowship in interventional radiology at St George’s Hospital London and Tan Tock Seng hospital, Singapore. His clinical interests lie in peripheral vascular interventions and interventional oncology.

I am currently a Professor of Radiology and Surgery in the Division of Vascular and Interventional Radiology at the Medical College of Wisconsin. I served as section chief for 13 years and now serve as Vice Chairman of Clinical Operations for the Department of Radiology. During my tenure at MCW, I have played an integral role in building an interventional oncology practice, and we were among the first in the country to offer liver directed therapies such as radioembolization and drug eluting bead transarterial chemoembolization (DEB-TACE). Because new therapies require research, my research interests are focused on image guided therapy for cancer in the liver, lung, kidney, and musculoskeletal system. I have served as the PI for multiple multicenter national and international trials investigating the integration of systemic and liver directed therapy for both primary and metastatic liver cancer, including the DEB-IRI, SIRFLOX and EPOCH

Position:
– Vice-Director of Radiologic Clinic
– Head of Department of Interventional Radiology

Specialization
– Diagnostic and interventional Radiology
– Interventional radiology since 2002 including use of microcatheters and micro-guidewires
– Specialist for diagnostic and interventional oncological Radiology in close collaboration with the hematologic-oncologic, radio oncology, urology, gynecology and surgery department, including prostate, ovarian, cervical, colorectal, gastric, esophageal, pancreatic and hepatocellular cancer (all including FDG-PET/CT staging and bone scans)
– Tumor (Chemo- & Radio-) Embolization, local tumor ablation with brachytherapy, thermal destruction (RFA, MWA) and irreversible electroporation (IRE)
– Experiences as Independent Reviewer & Adjudicator using RECIST, mRECIST, iRECIST, irRECIST, COI, WHO, Cheson, Lugano, PCWG3 and MacDonald Criteria

Publications:
https://pubmed.ncbi.nlm.nih.gov/?term=gebauer-b&sort=date

Dr Lawrence Quek, Senior Consultant, Department of Diagnostic Radiology, Tan Tock Seng Hospital. He graduated from Flinders University of South Australia. Dr Quek underwent radiology training in Singapore and became a fellow of Royal College of Radiologists and Royal Australian and New Zealand College of Radiologists. He also obtained Master of Medicine (Radiology), National University of Singapore (NUS).

As a practicing interventional radiologist, he has diverse interests in vascular, oncology, and musculoskeletal disciplines. As an educator, he is an adjunct Associate Professor in Lee Kong Chian School of Medicine, Nanyang Technological University, teaching body imaging. He is also a senior clinical lecturer with Yong Loo Lin School of Medicine, NUS.

Stephen Bird is a general sonographer living in Adelaide with over 30 years of clinical experience. He holds a General and a Vascular DMU and a Masters of Medical Sonography from the University of South Australia. He is an honorary fellow of ASUM and a life member of the ASA. He is a passionate educator, presenting regularly at national and international conferences as well as conducting weekend workshops for diagnostic medical ultrasound professionals. His educational resources are also available for all to enjoy at birdultrasound.com.au

I am a Senior Consultant Medical Oncologist, Director of Research for the Division of Medical Oncology as well as the Director of the NCCS-Satellite Tissue Repository at National Cancer Centre, Singapore. I’m also a clinician scientist (twice NMRC CSA awardee) and Associate Professor at Duke-NUS and faculty member and principal investigator of the laboratory of applied cancer genomics in the Precision Medicine and Population Genomics program at Genome Institute of Singapore, A-Star and adjunct faculty at Cancer & Stem Cell Biology Program at Duke-NUS. Nationally, I am the platform lead for tissue bank & databases for Singapore Translational Cancer Consortium (STCC) for CRIS, MOH, Singapore. I have an extensive publication record, with over 90 papers (h-index 39), including numerous first or senior/corresponding author contributions in the Journal of Clinical Oncology, Nature Genetics, Nature Medicine, Nature, JAMA. I have secured numerous individual competitive grants totaling over $6 million. Additionally, I am the principal investigator of a national collaborative grant on cancer liquid biopsies (IAF-PP, Calibre, $15 million) and serve as a co-investigator or platform PI on other national collaborative projects amounting to $43 million. I mentor several junior clinician scientists (including 2 NMRC transition awardees), post-doctoral fellows, PhD students, and clinician scientist PhD students. My research focuses on the immunobiology of colorectal cancer and non-invasive diagnostics. I have also been honored with the ASCO Young Investigator Award (2010), the ASCO Merit Award (2011), and the National Youth Award (2014), the country’s highest accolade for youths.

Dr Pua Uei read medicine in the National University of Singapore and received his post-graduate training in diagnostic radiology in Singapore. He obtained the Fellow of the Royal College of Radiologists (FRCR) and Masters of Medicine (Diagnostic Radiology) and was admitted as a Fellow of the Academy of Medicine, Singapore (FAMS).

An active researcher, his work is documented in more than 190 peer-reviewed publications and delivered over more than 300 lectures in over 20 countries. His contributions include visiting professorial lectures at leading US medical schools and serving as an International Visiting Professor for the Radiological Society of North America (RSNA) in 2017. He has led outreach programs providing relevant IR training in developing countries such as Myanmar, Kenya, Sri Lanka, Latvia, and Kazakhstan.
He is an Adjunct Associate Professor at the Yong Loo Lin School of Medicine, National University of Singapore, had received various educator awards including “Role Model” citation, “Best Teacher” and Special Recognition Award.

Dr. Pua has held several leadership positions, including President of the Singapore Radiological Society (2012-2016), inaugural Chair of the Chapter of Interventional Radiologists at the Academy of Medicine Singapore (2021-2025), and Founding and Board Member of the Society of Interventional Oncology (2018-2024).

A domain expert in both vascular intervention and interventional oncology, his innovative work has been featured in multiple major media outlets including Channel NewsAsia, MediaCorps news channels and print press (The Straits Times, ZaoBao, Berita Harian).

In recognition of his contributions, Dr. Pua has been elected as a Fellow in several prestigious societies. In interventional radiology, he is a Fellow of the Society of Interventional Radiology (FSIR) and the Cardiovascular and Interventional Radiological Society of Europe (FCIRSE). In endovascular intervention, he is a Fellow of the Society of Cardiovascular Angiography and Interventions (FSCAI) and the American College of Cardiology (FACC).

Dietmar Tamandl, MD is a radiologist who specialized in imaging for Gastrointestinal tract cancers and oncologic radiology. He grew up in Vienna where he graduated from Medical school. After serving in the Austrian Army, he started a residency in General Surgery at the Medical University of Vienna. He completed his training in 2009 and worked as a General Surgery Attending with special focus on Surgical Oncology at the Vienna General Hospital. His research focused on liver and biliary tract cancers, and he received the Venia docendi from the Medical University of Vienna for his research in that field (Assistant Professor). In 2010/11 he completed a Surgical Oncology Fellowship at the Memorial Sloan-Kettering Cancer Center in New York, where he was trained in Advanced Surgical Oncology procedures. His special focus was colorectal and hepatobiliary/pancreatic surgery. During that fellowship, his interested in radiology was raised and continued to increase after his return to Vienna in 2011. After working at the Surgical Department for almost another year, he decided to switch subjects and started a new residency in Radiology, which he completed in 2017. In 2017, he also passed the European Board Examination for Radiology (EBiR). Similar to his previous scientific interest, his main attention is abdominal and oncological radiology, and he also published several papers in that field. He has authored and co-authored around 95 peer-reviewed articles and 6 book chapters. He is a regular speaker at national and international conferences. He is reviewer for several radiological and surgical journals. In 2022, he received the Venia docendi for his radiological research in oncologic imaging. He continues to work at the Medical University of Vienna as an Associate Professor of Radiology and is currently the Department Head of Body CT at this institution. He is married and has three sons.

Working in Interventional Radiology as a Senior staff nurse currently. Received Bachelor of Nursing from Griffith University. Diligent nursing professional with 9 years of experience delivering exceptional care to inpatient ward patients and 3 years of working experience in Interventional Radiology.

Professor Annick Van den Abbeele is Professor of Radiology at Harvard Medical School; Chair Emeritus Department of Imaging, Institute Physician and Senior Faculty Scholar at the Dana-Farber Cancer Institute (DFCI); and Chief Emeritus of the Division of Cancer Imaging at the Brigham and Women’s Hospital (BWH). She designed and founded an integrated bi-directional preclinical and clinical translational cancer imaging research program (Center for Biomedical Imaging in Oncology), a dedicated cancer research cyclotron facility (Molecular Cancer Imaging Facility), and co-founded/co-directs an NCI-sponsored Dana-Farber/Harvard Cancer Center Tumor Imaging Metrics Core now established at 12 National Cancer Center Network sites and other institutions.

Professor Van den Abbeele served as the 2021-2022 President of the International Cancer Imaging Society, and the co-Editor-in-Chief of Cancer Imaging (2016-2024). She fosters academic, industrial, and governmental collaborative efforts to leverage teaching, clinical and research strengths, and resources globally, to maximize the translation of discovery in the most timely, cost-effective and efficient way, and offer significant synergies and partnerships across borders for the benefit of patients with cancer.

She thoroughly enjoys being a clinician-scientist, a teacher and a mentor, and has championed cancer imaging as a multidisciplinary specialty by founding the BWH/DFCI Cancer Imaging Program (CIP) Fellowship training radiologists as imaging clinician-scientists specializing in the multiparametric, molecular imaging and therapy of cancer as future leaders in the field of imaging. Many of the CIP graduates have successful careers at well-respected institutions locally, nationally and internationally.

Professor Van den Abbeele’s landmark use of molecular imaging to evaluate response to novel cancer drugs helped launch the groundbreaking development of novel therapies that revolutionized the field of oncology and helped establish molecularly targeted therapies, immunotherapies, and theranostics as new paradigms in the treatment of patients with cancer, for which she is nationally and internationally known.

I am a Professor of Radiology in the Abdominal Imaging/Body MRI Section in the Department of Radiology, and the BioMedical Engineering and Imaging Institute (BMEII) at the Icahn School of Medicine at Mount Sinai in New York. I completed medicine studies at Université d’Alger (Algeria) and Universite Paris VI (France) followed by a specialty in Diagnostic Imaging in Paris Public Hospitals (Internat des Hôpitaux de Paris), then a Master of Science in Paris XII University. I then pursued a post-doctoral fellowship at UCSF (in musculoskeletal imaging) followed by a clinical fellowship in Abdominal imaging at UCSF, and a Faculty position at NYU Medical center. I have been at Icahn Mount Sinai since late 2009. I am the director of Body MRI and Cancer Imaging in the Department of Radiology and BMEII, co-chief of the abdominal imaging section and vice-chair for translational research in the Department of Radiology. I am a clinician scientist with expertise in advanced MRI of the abdomen and pelvis. I direct the Body MRI quantitative group at BMEII, and my research is supported by NIH, foundation and industry funding. I have been named “Distinguished Investigator” of the Academy of Radiology Research, Fellow of the ISMRM, SAR, ICIS and SABI. I have authored over 268 peer-reviewed manuscripts mostly on Body MRI, and have mentored several students, residents, fellows and postdocs for research.

Jonathan Goldin, MD, PhD, earned his medical degree from the University of Cape Town Medical School in 1983, followed by a Ph.D. from the same institution in 1990. Dr. Goldin holds FRCR certification from the Royal College of Radiologists, UK, and is Board Certified by the American Board of Radiology since 2005. He has been licensed to practice in California since 1995 and currently holds the titles of Professor of Radiology and Medicine, as well as Executive Associate Chair of the Department of Radiology, at the David Geffen School of Medicine at UCLA.

Dr Gideon Ooi graduated from National University of Singapore and holds specialist qualifications in Diagnostic Radiology from the Royal College of Radiologists and National University of Singapore in 2017. He completed further specialist training in Nuclear Medicine, PET imaging and Theranostics in 2020 to become among a handful of dually-accredited Diagnostic Radiologist and Nuclear Medicine Physician.

In 2023, Dr Ooi received the prestigious National Medical Research Council Research Training Fellowship (NMRC RTF) to be among few nationally-selected Innovation Fellows in the Singapore Biodesign Programme that aims to nurture the next generation of medtech innovators for Singapore and Asia. During the fellowship, he underwent clinical immersion at Beijing Tsinghua Changgung Hospital in China, and received training at Stanford Byers Center for Biodesign at Stanford University and at Fogarty Innovation Institute in California, USA. He and his team filed for two provisional patents during the fellowship.

Dr Ooi also has research interests in oncologic imaging, theranostics as well as medical artificial intelligence. He is the Radiology and Imaging AI & Informatics co-lead of a national, multi-million dollar grant funded lung cancer screening trial in Singapore. He is also a Site PI of another multi-million dollar AISG grant-funded trial at NCCS.

He is also a Core Faculty member of the Nuclear Medicine Senior Residency Programme and Clinical Assitant Professor with Duke-NUS Medical School. He also serves as an executive committee member of Singapore Radiological Society.

Raman Uberoi is a consultant Interventional Radiologist at the John Radcliffe hospital, Oxford. He graduated from Cambridge university 1985 and has been working as an interventional consultant for over 26 years. He was the clinical lead and clinical director in the Oxford university hospitals and helped develop several interventional services including endovascular repair of aortic aneurysms (EVAR) including the complex fenestrated and arch branch stent grafting programs, gastro-intestinal stenting, fibroid embolization, pulmonary artery thrombolysis, distal venous arterialisations and pelvic congestion syndrome.

Passionate about improving outcomes and quality of care by making IR a more clinically focussed specialty through research and publication of quality standards and has authored over 180 articles in scientific journals as well a national and international standards guidance for the BSIR, Royal college of Radiologists, Cardiovascular society of Europe and NICE. Continues to work as Deputy editor for CVIR and senior editor for Clinical radiology and British journal of Radiology.

Held many national and international leadership posts including chair of many BSIR committee’s and President of the BSIR. He was elected to Treasurer and President of the radiology section of the Royal society of medicine. For the Royal college of radiologist’s chair of the regional leads, ISAS accreditation board, professional standards board, faculty boards and currently medical director of professional practice. For CIRSE member and chair of the standards of practice, local host CIRSE 2012 congress, Radiation protection task force, ESIR online, first research board, Chair of the membership and rules committee and twice chair of the Curriculum review taskforce. One of the biggest achievements has been the development and evolution of the EBIR through many roles for over 12 years including as chair of the EBIR board.

Awarded honorary membership by IRSA, Irish interventional society medal, Gruntzig lecturer, BSIR Gold medalist, Visiting professor Hong Kong and Graham plant professor jointly by the RCR and BSIR. But his proudest achievements are his 34-year marriage to Susan Uberoi and his two sons Adam and Jamie.

I was born in Massachusetts and grew up in central Wisconsin. I attended Princeton University, followed by a two year Fulbright Fellowship in Heidelberg, Germany. I returned to attend Medical School and Graduate School at the University of Wisconsin, and completed my MD and PhD training, with a focus on human cancer biology. After initial residency training in surgery, I completed my radiology and pediatric radiology training at the BI Deaconess hospital and Boston Children’s Hospital, respectively. I have been a staff Radiologist at Boston Children’s Hospital since 2001 and an Associate Professor of Radiology at Harvard Medical School (HMS) since 2010, with board-certification in Radiology (2000) and subspecialty certification in both Pediatric Radiology (2003) and Nuclear Radiology (2015). I have been the Director of Nuclear Medicine & Molecular Imaging since 2011 and have spearheaded our departmental Quality and Safety initiatives since 2007, including as Vice Chair for Quality and Safety from 2014-2020 and Physician Director of Quality and Safety since 2020.
For the past two decades I have also been active in the Children’s Oncology Group, through which I have become nationally and international recognized as a leader in pediatric oncology imaging. As Clinical Director of the NIH-funded, Children’s Oncology Group (COG) Phase I Consortium Imaging Center (2008-2018), and the COG Pediatric Early Phase Clinical Trials Network (PEP-CTN) Imaging Research Center (2018-present), I have focused on early phase clinical trials and the correlative imaging used to establish the efficacy of novel experimental therapies.
Between my COG and departmental research work, approximately 25% of my effort is NIH-funded and dedicated to COG clinical trials work, with 25% effort devoted to administrative and departmental leadership positions. The balance of my effort (50%) is spent in clinical service and in teaching Radiology residents, Pediatric Radiology fellows, and Nuclear Medicine fellows.

Olivier Lucidarme is Professor of Radiology at Sorbonne University and is Head of the radiology departement at La Pitié Salpêtrière Hospital in Paris since 2016. He was awarded a PhD in 2003 for his research into functional imaging of angiogenesis at Sorbonne university and the Imaging Research Laboratory at Hillcrest Hospital in San Diego (University of San Diego California, USA).His speciality is abdominal imaging.

Richard M. Gore, Md is a Professor of Radiology at the University of Chicago Prittzker School of Medicine. And Chief of Gastrointestinal Radiology at North Shore University Health System. He is Past President of the Society of Gastrointestinal Radiology and is Senior Editor of Textbook of Gastrointestinal Radiology currently in its 5th Edition. He has received the Gold Medal from the International Cancer Imaging Society and the Canon Medal from the Society of Gastrointestinal Radiology. His Academic Interests include Staging Gastrointestinal Cancers, Inflammatory Bowel Disease, and Thoracic and Abdominal Complications of Novel Cancer Therapies.

Harriet C. Thoeny, MD is full professor of radiology at the University of Fribourg in Switzerland and is chairperson at the Cantonal Hospital of Fribourg and consultant at the Department of Urology at the University of Bern. She is specialized in Urogenital and Head & Neck Radiology with main focus on oncological and functional imaging. She is associate editor of Radiology, fellow of the International Cancer Imaging Society (ICIS), the European Society of Urogenital Radiology (ESUR), the European Society of Head & Neck Radiology (ESHNR) as well as honorary fellow of the Asian Society of Abdominal Radiology (ASAR). In addition she become honorary member of the Spanish Society of Abdominal Radiology (SERAM), the French Society of Radiology (SFR), the Radiological Society of America (RSNA) and has been recently appointed fellow of the International Society of Magnetic Resonance in Medicine (ISMRM).

Associate professor, fellow of ICIS,fember of the female pelvic imaing working group of the ESUR; past president of the Austrian society of Radiology; specialist in MRI and CT in female pelvic imaging, specialist in body oncologic imaging, lecturer in many postgraduate courses (ICIS, ESUR, ECR, Erasmus, AAF…)

Work experience

• 2024 TCH Austin Texas
• 2015-2023: Pediatric (neuro) radiologist at the Department of Radiology of the University Medical Center Utrecht/Wilhelmina Children’s Hospital and Princess Máxima Center for Pediatric Oncology
• 1997-2015: Pediatric (neuro) radiologist at Sophia Children’s Hospital Rotterdam, The Netherlands Education
• 2000: PhD Erasmus University of Rotterdam, The Netherlands
• 1999: Fellowship pediatric neuroradiology at USCF (Prof A.J. Barkovich), San Francisco, USA
• 1991-1996: Residency in Radiology, Erasmus Medical Center Rotterdam, The Netherlands
• 1990: MD Leiden University Medical Center, Leiden, The Netherlands Scientific responsibilities and positions of trust
• Dr. Maarten Lequin is an accomplished medical practitioner and researcher. He is now one of the pediatric radiologists at TCH Austin, with focus on body imaging, neuro imaging and fetal imaging.

He leads the clinical radiology and radiological research departments at the Wilhelmina Children’s Hospital and Princess Maxima Center, two renowned pediatric care and oncology hospitals in the Netherlands. Dr. Lequin’s research focuses on using neuro-imaging techniques on children and adolescents, including premature babies. Since joining the National Pediatric Oncology Center in April 2015, he has devoted himself to researching neuro-oncology imaging. Dr. Lequin has authored numerous articles and book chapters on advanced imaging in pediatric brain tumor patients, mainly focusing on cerebral perfusion to monitor recurrence and metastases using arterial spin labeling. He is also involved in a 7T project that investigates metabolic imaging in patients with pediatric brain tumors, as well as researching the use of machine learning to analyze magnetic resonance spectroscopy data to predict the biological behavior of these tumors more accurately. Dr. Lequin’s extensive research has published over 260 articles in leading international journals, including many on neuroimaging.

Publication record: 280 publications, 9472 citations, H-index: 52

Hedvig Hricak, MD, PhD, Dr. (h.c.m)
Memorial Sloan Kettering Cancer Center

Hedvig Hricak, M.D., Ph.D., Dr. (h.c.m) holds the Carroll and Milton Petrie Chair of Radiology at Memorial Sloan Kettering Cancer Center, New York, NY. She is a member of the Molecular Pharmacology and Chemistry Program at Sloan Kettering Institute, Professor Gerstner Sloan Kettering Graduate School of Biomedical Sciences, and Professor of Radiology at Weill Cornell College of Medicine, New York, NY. The hallmark of her academic career has been developing, translating, and disseminating new diagnostic imaging techniques, primarily for genitourinary cancers. She is actively engaged in facilitating the development and implementation of integrated diagnostics in oncology. In addition, she is engaged in global health initiatives promoting international education and collaboration to improve quality and access to oncologic imaging and cancer care. She has chaired the National Cancer Policy Forum (NCPF) workshop “Improving Cancer Diagnosis and Care.” She served as Lead Commissioner of the Lancet Oncology Commission on Medical Imaging and Nuclear Medicine, and presently, she serves as co-chair on the Lancet Oncology Commission-Moonshot 2.0, addressing the global workforce shortage in cancer care.
She is an elected member of the National Academy of Medicine (NAM) of the United States and received the David Rall Medal, the NAM award for distinguished leadership. She has also received eight gold medals and 23 honorary fellowships from radiological societies around the world. She holds honorary doctorates from the Ludwig Maximilian University, Munich, Germany, and the University of Toulouse III, Paul Sabatier, Toulouse, France.

Dr Kirsten Gormly is a consultant radiologist with Dr Jones and Partners Medical Imaging in Adelaide, and Clinical Senior lecturer with The University of Adelaide South Australia, with sub-specialty expertise in oncology imaging and pelvic MRI. She trained in rectal MRI at the Royal Marsden Hospital, London with Professor Gina Brown from 2002-4 and instituted rectal MRI services in a number of hospitals in South Australia. She has been involved in several multidisciplinary trials in rectal cancer and has a focus on the quality of MRI technique and reporting globally. Kirsten is a highly regarded educator in rectal MRI, regularly giving lectures and workshops in Australia and New Zealand and has been an invited speaker at SAR, ESGAR and ISMRM as well as contributing to Radiology Across Borders. She co-ordinated the rectal day of the biannual Intensive Pelvic MRI workshop from 2012-2019, held in Melbourne, Sydney and Singapore. In addition Dr Gormly has an interest in MRI for prostate and gynaecological cancers, benign gynaecological conditions and female urology, as well as general oncology CT, including Dual Energy CT in the abdomen. She has promoted the use of templates in cancer imaging since 2008, and aims to make accurate reporting as easy as possible for all radiologists.
Dr Gormly is past chair of the Abdominal Radiology Group of Australia and New Zealand (ARGANZ), promoting radiologist education and collaboration between radiologists and clinicians in abdominal imaging, and was made a Corresponding Fellow of ESGAR in 2023. She is a member of the Australasian Gastrointestinal Trials Group (AGITG) lower GI working party and the South Australian Prostate Cancer Clinical Outcomes Collaborative (SA PCCOC) research committee.

Evis Sala is a Professor of Radiology and Director of the Radiology Training Program at Università Cattolica del Sacro Cuore and Chair of Department of Diagnostic Imaging and Radiotherapy at Fondazione Policlinico Universitario Agostino Gemelli IRCC, Rome. Italy. Previously she was the Professor of Oncological Imaging at the University of Cambridge, UK and co-led the Cancer Research UK Cambridge Centre Advanced Cancer Imaging and the Integrated Cancer Medicine Programs. From 2012 to 2018, she served as the Professor of Radiology at Weil Cornell Medical College and Chief of Body Imaging Service at Memorial Sloan Kettering Cancer Center in New York.

Her research integrates quantitative imaging methods for evaluation of spatial and temporal tumour heterogeneity with genomics, proteomics and metabolomics. She is leading multiple research projects focusing on the development and implementation of artificial intelligence methods for image reconstruction, segmentation, and data integration. In recognition for her contribution to education and research in oncological imaging she received the Radiology Society of North America (RSNA) Honoured Educator Award in 2014, 2017 and 2020 and was elected Fellow of the International Society for Magnetic Resonance in Medicine in 2015 and awarded an Honorary Membership of RSNA in 2022 and an Honorary membership of the Japanese Society of Radiology in 2024.

Professor Ann King is currently appointed as Professor of Radiology and Honorary Consultant in the Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong (CUHK). She possesses the qualifications of MBChB, FRCR & FRCP (UK), FHKCR & FHKAM (HK) and received her Doctorate (MD) on MRI of nasopharyngeal carcinoma in 2008.

She is a Head & Neck radiologist with nearly 30 years of research experience in MRI of Head & Neck cancer, including nasopharyngeal cancer (NPC). She has published numerous papers on MRI of NPC and is currently working on MRI detection of early-stage NPC in EBV screening programs. She also has published research in other Head & Neck cancers, functional MRI techniques, including DCE, DWI, MRS, and CEST, the post-treatment neck, and more recently applications of AI. She has obtained competitive grants, published book chapters, over 230 peer-reviewed papers (H-index 53), including articles in the New England Journal of Medicine, Annals of Oncology, Radiology, European Radiology, and American Journal of Neuroradiology. She has been a member of international consensus working groups and scientific committees and has delivered numerous international lectures.

She has many years of experience teaching and training. She has a long career serving on university committees and for 20 years has developed and coordinated the medical student radiology teaching program which spans the curriculum. She has also been an active member of the Hong Kong College of Radiologists for over 15 years, during the establishment of the Hong Kong radiology training program, serving on the education committee, and accreditation subcommittee and as an examiner for the Hong Kong College and Royal College of Radiologists.

Fred Prior, Ph.D. is Distinguished Professor and Chair of the Department of Biomedical Informatics and Professor of Radiology at the University of Arkansas for Medical Sciences (UAMS). Dr. Prior has extensive R&D experience in industry and academia, focused on the design of advanced medical information management and imaging technologies. He has held senior management positions in a variety of R&D environments ranging from Silicon Valley startups to major multi-national corporations in the US and Europe.

Dr. Prior’s research interests include cancer informatics, machine learning analysis of medical imaging, data publication, and neuroimaging informatics. He serves as principal investigator and director of the US National Cancer Institute’s Cancer Imaging Archive project and is a Work Package lead in an EU funded project, EuCanImage, to develop a platform for distributed data management and machine learning to advance precision medicine in oncology.

Dr. Prior directs informatics efforts for the UAMS Translational Research Institute and Pediatric Clinical Trial Network. He is an associate editor of several leading scientific journals, and a reviewer for numerous scientific and engineering journals as well as U.S. and European funding agencies. He is the author of over 170 scientific publications and holds 6 US and international patents.

Associated Professor Dr. Keerati Hongsakul is on the current President of the Thai Society of Vascular Intervention Radiology (TSVIR) as well as executive board of Asia-Pacific Society of Cardiovascular and Interventional Radiology.

He is a director of the Minimally Invasive Surgery and Interventional Radiology center as well as a consultant cardiovascular & interventional radiologist at Songklanagarind Hospital, Prince of Songkla University, Songkhla, Thailand.

His main clinical & research interests are dialysis & venous intervention procedures.

Thierry A.G.M. Huisman is the current Radiologist-in-Chief and Chair of the Department of Radiology at Texas Children’s Hospital (TCH) in Houston, USA. He also holds the Edward B. Singleton Chair of Radiology. He is a tenured Professor of Radiology, Pediatrics, Neurosurgery, Neurology, Obstetrics and Gynecology at Baylor College of Medicine and holds adjunct Professor Appointments at Johns Hopkins School of Medicine in Neurosurgery and Pediatrics. Before he joined TCH he served 11 years at Johns Hopkins Medicine in Baltimore. He was the Chairman of the Department of Imaging and Imaging Science at the Johns Hopkins Bayview Medical Center. His primary field of expertise and research focuses on advanced, quantitative, precision imaging in the field of Neuroradiology. He has given more than 480 invited lectures, published 430 articles and 31 reviews, 67 book chapters, 6 text books, serves on multiple scientific committees of the various radiological societies and has organized multiple national and international meetings in Europe and the USA. He has been one of the founding members of the Swiss Symposium in Pediatric Neuroradiology and the Neurointensive Care Nursery at Johns Hopkins. Dr. Huisman served as a faculty member of the AIRP course in Washington, DC (2013-2019), and is a course advisor for the IDKD course in Davos, Switzerland since 2012. He is a reviewer for multiple scientific journals and is an editorial member of 5 journals. He served as president of the American Society of Pediatric Neuroradiology (2014/15) and the Eastern Neuroradiological Society (ENRS) (2020/2021), is a fellow of the International Cancer Imaging Society, the Global Newborn Society, the American College of Radiology, and the American Society Pediatric Neuroradiology. He is the elected President of the International Cancer Imaging Society. Finally, he served as senior editor of the American Journal of Neuroradiology 2015-2023.

Dr Mangat qualified from the University of Wales College of Medicine, UK in July 1993.

Basic Surgical Training in the United Kingdom and Australia, he obtained the Fellowship of The Royal College of Surgeons, London.
1994-1999

Radiology Training Scheme in the West Midlands, UK.
1999-2004

His Fellowship of the Royal College of Radiologists, London was obtained during this period and there was a one year dedicated Fellowship in Interventional Radiology. He also developed a sub-specialist interest in Hepatopancreaticobiliary (HPB)/Liver Imaging and Intervention during the later period of this training and thus a 3 month sabbatical period was spent in the University of California, San Diego learning enhanced methods of Liver MRI.

Consultant HPB/Interventional Radiologist at the Queen Elizabeth University Hospital Birmingham, UK (QEHB) working with the Liver Unit.

February 2005 to September 2014

The Liver Unit at QEHB is one of the largest in the world hence a diverse and in-depth knowledge of all HPB problems was obtained.

Rod is a Professor of Medicine at the University of Melbourne and at Monash University. He was previously the inaugural Director of Cancer Imaging at the Peter MacCallum Cancer Centre and is an internationally-recognized pioneer in oncological PET imaging and therapeutic nuclear medicine with more than 30-years’ experience in both. He has recently founded a company to perform research and development into the emerging field of theranostics and has installed an ultra-extended-field-of-view PET/CT scanner at the Melbourne Theranostic Innovation Centre (MTIC) in North Melbourne.
He was inducted as a Fellow of the Australian Academy of Health and Medical Science in 2015 and was the recipient of the 2019 International Cancer Imaging Society Gold Medal for contributions to oncological imaging and 2021 Peter E. Valk Memorial Award of the Society of Nuclear Medicine for lifetime achievements in clinical PET. In June 2023, he received the Saul Hertz Award from the Society of Nuclear Medicine for his contribution to the field of theranostics. He was also awarded an Order of Australia Membership (AM) in the General Division in the King’s Birthday Honours of 2023.
He has published over 650 peer-reviewed manuscripts including contributions in the New England Journal of Medicine, Journal of Clinical Oncology, the Lancet, Lancet Oncology, Clinical Cancer Research, Nature Reviews Clinical Oncology, Nature Communications, and the Journal of Nuclear Medicine. His H-index is over 100 with more than 40,000 lifetime citations (Google Scholar).
Professor Hicks ran the Translational Research Laboratory and Pre-Clinical Imaging Facility at the Peter MacCallum Cancer Centre from 2002-2021 and has a strong research interest in the linking of genotype with molecular imaging phenotype and personalized selection and delivery of radionuclide therapy, including combinatorial therapies. He has been actively involved in developing and clinically implementing novel radiopharmaceuticals for diagnostic and therapeutic applications.

Jay P. Heiken, MD, FACR, is a Consultant at the Mayo Clinic in Rochester, Minnesota and Professor of Radiology at the Mayo Clinic College of Medicine. Prior to that he was on the faculty of the Mallinckrodt Institute of Radiology at the Washington University School of Medicine for 35 years. He served as Director of Abdominal Imaging at Washington University for 15 years and as Co-director of Body Computed Tomography for 24 years. Dr. Heiken earned his bachelor’s degree at Williams College in Williamstown, Massachusetts, where he graduated magna cum laude before receiving his medical degree from Columbia University College of Physicians and Surgeons in New York, New York. He completed his internship in internal medicine at Emory University Affiliated Hospitals in Atlanta, Georgia, and his residency in radiology at Columbia-Presbyterian Medical Center in New York. He completed a fellowship in abdominal radiology at the Mallinckrodt Institute of Radiology at the Washington University School of Medicine in St. Louis, Missouri.

Dr. Heiken is past President of the International Cancer Imaging Society (ICIS), the Society of Computed Body Tomography and Magnetic Resonance (SCBT/MR) and the Society of Gastrointestinal Radiologists (SGR). He is a fellow of the American College of Radiology, and for 22 years served as an examiner for the American Board of Radiology. He has served on the editorial board of Radiology and currently is a member of the editorial board of Abdominal Radiology, the Korean Journal of Radiology and Applied Cancer Research. He has been awarded Honorary Fellowship in the Asian Society of Abdominal Radiology (ASAR) and Honorary Membership in the Radiological Society of South Africa (RSSA) and the Japan Radiological Society (JRS). Dr. Heiken has received the Gold Medal of the Society of Abdominal Radiology, the International Cancer Imaging Society and the Society for Advanced Body Imaging.

Siva Srinivasan MD, FRANZCR, FRCR, EBIR, FCIRSE is a senior consultant in Diagnostic and Interventional Radiology in KTPH, Yishun Health Singapore. Interests include hepatobiliary radiology and interventions, and management of pulmonary embolism. Publications > 50. Presented in local/international conferences.

Stefanie Wai Ying Yip is an Associate Consultant at the Department of Imaging & Interventional Radiology in the Prince of Wales Hospital, Hong Kong, and a Clinical Associate Professor of the Chinese University of Hong Kong. Her major subspecialty is musculoskeletal radiology, and she has also completed subspecialty training in neuroradiology and interventional radiology. After graduating from the University of Hong Kong medical faculty with distinction and as the youngest graduate in her class, Dr. Yip completed her residency in the Prince of Wales Hospital where she continues to work today.

In addition to clinical, on-call, and teaching duties, Dr. Yip actively pursues research and is the acting Chairperson of the Asian Musculoskeletal Society (AMS). She has served on the editorial board of the Hong Kong Journal of Radiology and as an invited examiner for the ReviseRadiology FRCR2B preparatory course. She is a regular contributor to locoregional and international radiology conferences, having delivered presentations that were awarded the AMS Best Paper Award twice, the Hong Kong College of Radiology (HKCR) Best Oral Presentation Award twice, the Young Presenter’s Award in Radiology, and recently the American Roentgen Ray Society (ARRS) Emerging Research Gold Medal 2023.

Outside of radiology, Dr. Yip enjoys playing table tennis at a competitive level. She is the defending ladies singles champion in the Hong Kong Medical Association (HKMA) annual table tennis tournament, the 2023-2024 Hong Kong Doctors’ Union (HKDU) champion in ladies singles and ladies doubles, and was also awarded the HKMA Sports Lady of the Year.

Rola Husain, a diagnostic and interventional musculoskeletal radiology consultant from the Kingdom of Bahrain, working in Salmaniya Medical Complex – Governmental Hospitals.
Rola is a holder of both the Arab and European boards of Radiology, with two MSK fellowships from Mount Sinai hospital (NYC) and Vancouver general hospital (Canada).
She is a lecturer in the Arabian Gulf Medical University in Bahrain and a core lecturer of the family physician program in Bahrain. She is a reviewer at the European Journal of Radiology and the journal of computed tomography.

She is the secretary of the Arabian Gulf Society of Skeletal radiology and their representative at the Asian Society of MSK. She is a member of the Bahrain Association of Sports Medicine, Society of skeletal Radiology, the International Pain and spine Intervention Society, as well as the American Society of Pain and neuroscience.

Chief Consultant: SWARNA SCANS, Vijayawada and Director :Ojasviteleradiology.com
Hon.Prof .of Radiology: NRI Academy of Sciences, CHINAKAKANI & Red cross Hospital, XiAn Jaiotong University,XiAn.China

Academic Qualifications: MD RADIODIAGNOSIS
Publications: 11  Presentations: 293, Editor of Volume 6 of Comprehensive text book of radiology by IRIA and Elsevier
Areas of interest: MSK Imaging & Body imaging
Awards and Achievements:
*Second best Scientific Exhibit – MR Imaging of Brachial Plexus, AMS, 2013,Qatar
*3rd Best Paper 3D CT in Craniofacial Trauma –MSS, Vijayawada -2013.
2nd Best Scientific Exhibit- MR Traumatic Brachial Plexopathy ISNR, Bangalore-2014.
*Ms.German Remedies Traveling fellowship Award for the Year 2000
*Fellow of Indian College of Radiology (FICR)
*Dr Miher Mitter National Oration award of ICRI -2016
*Dr. M L Agarawal National Oration award of IRIA-2017
*IRIA President Appreciation award -2019 2020 2021 2022
*Dr Chaya memorial Oration of IMA -2024

Positions Held
President National IRIA 2024
Chairman ICRI– 2021 – 2022
President IRIA APSTATE -2021-2022
Vice President, National IRIA – 2014
Joint Secretary, Musculoskeletal Society of India- 2013-2015
Governing Council Member, ICRI -2015 -16
General Secretary – Musculoskeletal society of India – 2015-17, 2017-19
President – Musculoskeletal society of India -2019-2021
Secretary, Indian College of Radiology & Imaging -2017-19
Education Committee member AOSR -2021-2023
Global Steering group Member for QSI of Royal College of Radiology -2021-24
President Elect Asian Musculoskeletal Society -2023-25
Secretary, Asian Musculoskeletal Society – 2021-23 Ec Member -2019-2021

Society Membership
Life member: Indian Radiological and Imaging Association
Life member: Indian College of Radiology and Imaging
Life member: Indian Medical Association
Life Member: Asian Musculoskeletal Society Member ESSR
Founder Member: Musculoskeletal Society of India, Member – Asian Musculoskeletal Society.
Life member: Indian Cartilage Society, Member ESSR

Dr. Goh is a consultant radiologist at National University Hospital. His main interest is to improve breast imaging through the means of research. He is a 3 time NMRC national grant winner with research projects involving the use of Contrast Enhanced Mammography (CEM) as well as a novel optical technique called photoacoustics.

Subba Digumarthy is a thoracic radiologist specializing in lung cancer imaging. I published over 160 original papers in various aspects of thoracic imaging with primary focus in lung cancer, and newer imaging techniques. He authored several review articles and text book chapters and edited a major text book of on thoracic imaging. I received multiple research grants and recipient of several awards and honors

Stefan Diederich, MD, PhD is a diagnostic and interventional radiologist at Marien Hospital Duesseldorf, Germany where he is chairman of the department of diagnostic and interventional radiology.

Prof Koh obtained his primary medical degree in Singapore (1989). Following further training in internal medicine and diagnostic radiology, he was awarded the fellowship of the Royal College of Radiologist (UK) in 1996. He was appointed to the position of Consultant Radiologist in Functional Imaging at the Royal Marsden Hospital in January 2008 and was conferred the title of Professor in Functional Cancer Imaging at the Institute of Cancer Research in 2015.

Prof Koh’s current clinical and research interest is in the development and application of functional imaging techniques for tumour assessment. He has a particular interest in developing and evaluating diffusion-weighted MR imaging in the body (DWI), to enhance and improve the ability to detect and characterise tumours, as well as to monitor the effects of conventional and novel therapeutics.

Prof Koh is the Imaging Theme Lead for the National Institute of Health Research (NIHR) Biomedical Research Centre at the Royal Marsden Hospital and Institute of Cancer Research. In 2015, he was appointed a member of the National Cancer Research Institute (NCRI) Imaging Biomarker Advisory Board in the UK.

In addition to his research, Prof Koh lectures regularly at numerous conferences and courses, including the European Congress of Radiology (ECR), European School of Radiology (ESOR), European Society of Gastrointestinal and Abdominal Radiology (ESGAR), International Society of Magnetic Resonance in Medicine meetings (ISMRM) and the Radiological Society of North America (RSNA) meetings. He was named outstanding teacher by the ISMRM in 2008, 2009 and 2012.

Prof Koh was elected a Fellow of the International Cancer Imaging Society (ICIS) (2007) and appointed Honorary Treasurer of the Society in 2011. He is series organiser for the ICIS interactive courses, a hands-on teaching course; and also the course organiser of the Body DWI course on behalf of the ESMRMB School of MRI.

Prof Koh is currently an associate editor for Radiology, and also reviews regularly for other radiological and medical journals. He was awarded the Barclay Medal in 2013 for his contributions to the British Journal of Radiology. Prof Koh has had numerous publications in peer reviewed journals and textbooks. In 2009 he co-edited a book, ‘Diffusion-weighted MRI: Applications in the Body’, published by Springer.

Dr Zhuang Kun Da is an Interventional Radiologist with special interests in dialysis access, interventional oncology and palliative procedures.

Professor of Radiology, Orthopedics and Palliative Care at the University of British Columbia and former Section Head Musculoskeletal Imaging at the Vancouver General Hospital in Vancouver, British Columbia, Canada and previous Fellowship Program Director. A medical graduate of McGill University in Montreal, Canada. Completed a Fellowship in musculoskeletal radiology at the University of California San Francisco with Prof Clyde Helms.

Previous Editor in Chief of the Canadian Association of Radiologists Journal (2009-2019) and currently Associate Editor of the British Journal of Radiology, Advisor to the Editor Medical Journal of Australia. North American Liaison for the Asian Pacific Association of Medical Journal Editors. Author of 490 published papers, 200 abstracts, 120 scientific exhibits, 5 books and 40 book chapters. Trained 90 post graduate fellows in musculoskeletal imaging. Member of the International Skeletal Society, Fellow of the Society of Interventional Radiology and Honorary Fellow of the Faculty of Radiology of the Royal College of Surgeons in Ireland.
Principle research interest includes musculoskeletal tumor imaging and Interventional imaging guided musculoskeletal procedures – particularly with regards to pain control in metastatic bone disease.

Prof. Anwar Padhani is an internationally recognized Oncological radiologist at Mount Vernon Cancer Centre, London, UK. He is a Professor of Cancer Imaging at the Institute of Cancer Research, London. He is a trustee of the International Cancer Imaging Society and co-chair of the International Prostate PI-RADS committee. Prof. Padhani has a passion for teaching having delivered over 450 lectures at scientific and educational meetings including several plenary talks. To his credit, he has been awarded several education awards including outstanding teacher from the ISMRM, and many honoured RSNA educator awards. He is active on social media on the X/Twitter handle @ProfPadhani and has a YouTube channel where he posts most of his lectures for free viewing. Prof. Padhani has a very high h-index (93) having published >500 citable articles including chapters in 33 textbooks, 30 case reports, commentaries, and editorials, 100 educational and scientific journal reviews, and over 200 original scientific articles in PubMed journals, with >80K publications reads and over 31K citations.

Giovanni Morana is Director of Radiological Department General Hospital Treviso. He has been teaching radiology in several academic courses at the University of Verona and Padova. Member of many Professional Societies, he is reviewer for several journals.

He has been Member of the Scientific Commission for ECR, ESGAR, ICIS. Member of European Commitee of RSNA (2018-2020). Member of Committee on International Radiology Education (CIRE) of RSNA (2020-2023). Meeting president of the 22nd annual meeting of the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), Venice, May 21-24, 2011. He has been President of the International Cancer Imaging Society (ICIS) for 2019. Gold Medal of International Cancer Imaging Society (ICIS) for 2022.

He has published 103 papers indexed in pubmed and scopus, 2 books (Editor), 30 chapters of book. He has been cited in 1840 papers. H-index 56 (Google Scholar). He has been given more than 400 lectures either in national and international meetings. He has been organized several meetings mainly focused on body MR (lung, abdomen) and Gastro-intestinal imaging. His main field of interest are MR IMAGING OF LIVER AND PANCREAS, MR IMAGING OF THE LUNG IN CYSTIC FIBROSIS, CONTRAST MEDIA.

Dr. Khaled Elsayes is a professor and director of faculty development, The University of Texas MD Anderson Cancer Center and The University of Texas John P. and Katherine G. McGovern Medical School in Houston. Dr. Elsayes currently serves as the President of University of Texas Shine Academy of Health Science Education, chief editor of Academy of Online Radiology Education, and he leads many national efforts such as serving as the chair of LI-RADS education and outreach committee as well as serving as the associate editor for Radiographics. Dr. Elsayes is a well-known world-renowned radiologist with more than 250 peer review publications and 400 abstracts, 200 visiting professorships and over 150 international awards (including 2014, 2017 and 2018 RSNA honored educator award, Society of Abdominal Radiology 2017 Richard Marshak Award and 2021-2022 Igor Laufer Visiting Professor Award).

Dr. Elsayes is an imminent speaker in national and international conferences, fellow of numerous international societies. He is also editorial member of several international journals and author of three radiology textbooks; “Introduction to Diagnostic Radiology” published by McGraw-Hill, “Cross Sectional Imaging of the Abdomen and Pelvis” published by Springer, “Pitfalls of the Abdomen and Pelvis” published by Elsevier.

Dr. Khaled Elsayes currently serves as the president of University of Texas Kenneth Shine Academy for Health Science Education. He enjoys partnering with many wonderful, intelligent colleagues. He holds honor in helping others and brings value and contributions that focus in teaching and centering the newest and most up-to-date information to his mentees. Partners to present the newest technologies and improved methods and processes for diagnosis and creating an action plan to help treat patients and fight the disease.

Dr. Patrick Asbach is a body imaging radiologist at the Charité in Berlin, Germany. He holds a professorship in diagnostic radiology at the Freie Universität Berlin and the Humboldt Universität zu Berlin. As a committed educator, Dr. Asbach has delivered over 100 lectures at conferences worldwide, and he was scientific organizer of several workshops on urogenital imaging. He has contributed to the literature through book chapters, commentaries, editorials, and over 100 scientific papers in PubMed citable journals. Dr. Asbach is fellow of the International Cancer Imaging Society (ICIS).

Dr Elaine Lee received her undergraduate medical training at the University of Nottingham, UK.

She completed her specialist training in radiology and fellowship in Wales, UK. She joined the Department of Diagnostic Radiology at the University of Hong Kong in 2010. Here, she developed her subspecialty interest in gynae-oncology, specifically in the application of functional and molecular imaging techniques in this field. She is the first advocate of intravoxel incoherent motion imaging (IVIM), a novel MRI technique in cervical cancer. More recently, her work has evolved around the applications of radiomics and AI in gynaecological cancer imaging. Her published works include > 100 original articles and abstracts in the field of Radiology and
Nuclear Medicine and an invited book chapter contribution in the seminal book on IVIM by Professor Le Bihan, a pioneer and world-renowned researcher on diffusion MRI technology. She is the primary investigator and recipient of competitive national grants in advancing the research in gynae-oncology imaging with established international and national collaborations. She is a Fellow of the International Cancer Imaging Society since 2022.

Apart from Research and Scholarship, Dr Lee has taken an active role in Teaching and Learning. She has led the first structured undergraduate ultrasound curriculum in Hong Kong, leading to the award of HKU Faculty of Medicine Teaching Medal in 2019. She has been instrumental in introducing new pedagogies in the undergraduate teaching with several pedagogy publications, the most recent being the application of AI in providing feedback on learning ultrasound skills among medical students.

Anju Sahdev is a Professor of Clinical Diagnostic Imaging, Radiology Consultant and a Director for Research at St Bartholomew’s Hospital, Barts Health, London.

She graduated from University of London in 1991, completed her Radiology training at University College London and St Bartholomew’s Hospital, becoming a fellow of Royal College of Radiologists in 1998.

Professor Sahdev’s specialties are imaging in oncology, particularly uro-oncology, endocrine adrenal diseases and benign and oncological gynaecological diseases using all imaging modalities.

She has authored and co-authored over 100 peer reviewed publications and has authored 23 chapters in clinical and imaging textbooks. She has delivered over 70 lecturers at national and international meetings. She is the senior editor for the reference textbook Husband and Reznek Imaging in Oncology, CRC Press published 2020 and the senior editor for Imaging in Endocrine disease in draft.

She is an associate editor for British Journal Radiology and Cancer Imaging and reviewer for several peer review journals, including Clinical Radiology, American Journal Radiology and Cancer Imaging, and a member of educational subcommittee of International Cancer Imaging Society. She is the gynaecological imaging module lead for UK National i-refer and RITI e-learning programme.

As the Director for Imaging research she has responsibility for delivering the operations and infrastructure to support imaging within Barts Health clinical trials. She is also a clinical radiation expert and an imaging guardian for North Thames Clinical Research Network. Her personal trial portfolio includes principal investigator and co-investigator for several imaging and COVID vaccine trials.

Dr. Lin is Professor of Radiology in Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Taiwan. He is the founding Director of Clinical Metabolomics Core (CMC) in Chang Gung University and Chang Gung Memorial Hospital Taiwan. The CMC is a new interdisciplinary program that has a focused clinical and research interest in the integration of clinical imaging, image guided surgery, biofluid analysis, clinical oncology and molecular therapeutics in order to drive the discovery, development and deployment of novel molecular biomarkers and targeted therapeutics to guide patient care in oncology. He and his team have pioneered the field of molecular imaging, with conventional imaging modalities such as CT, PET and MRI, for discovery of image-based molecular surrogates of tumor biology and clinical imaging biomarkers for treatment response to targeted therapies. Starting from gynecology oncology, the CMC have demonstrated the robustness and scalability of this approach in a broad spectrum of cancers to improve patient care.

Dr. Fiona Fennessy, MBBCh PhD FACR FSAR is a Professor Radiology at Harvard Medical School and Institute Physician at Dana Farber Cancer Institute. She has significant clinical expertise in cancer imaging, particularly prostate and gynecological cancer, and extensive research experience in quantitative MR imaging. She has been Principal Investigator on NIH awards, including a current NIH T32 entitled “Training in Image Guidance, Precision Diagnosis and Therapy”, and was the recipient of a Distinguished Investigator Award from The Academy for Radiology & Biomedical Imaging Research. She is Vice Chair of Faculty Affairs at Brigham and Women’s Hospital and Vice-Chair of the Alliance of Leaders in Academic Affairs in Radiology at the Association of Academic Radiologists.

Dr. Chung graduated Seoul National University College of Medicine and trained at Seoul National University Hospital as a resident and clinical fellow. He is an interventional radiologist and educator, specifically focu